Global cell-free protein expression market is estimated to be valued at US$ 280.2 million in 2022 and is expected to exhibit a CAGR of 6.4% over the forecast period (2022-2030).
Figure 1. Global Cell-Free Protein Expression Market Share (%), By Region, 2022
Rising cases of chronic diseases such as cancer, diabetes, cardiovascular disease, and others creates a demand for personalized medicine which can be achieved using cell-free protein expression. This is expected to drive growth of the global cell-free protein expression market over the forecast period.
Figure 2. Global Cell-Free Protein Expression Market Value (US$ Mn), By Product Type, 2022
Increasing marketing strategies by key players to increase awareness about advancements in their cell-free protein expression systems is expected to drive market growth over the forecast period.
For instance, on June 1, 2022, Codex DNA, Inc., a U.S.-based synthetic biology company announced that it would be presenting its BioXp system and RapidAMP technology for antibody and protein engineering workflows at Antibody Engineering and Therapeutics Europe Conference held from June 7 to 9, 2022. BioXp system provides hands-free, end-to-end automation of DNA assembly, cloning, amplification, and mRNA synthesis in a single run.
Cell-Free Protein Expression Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients